Association study between kynurenine 3-monooxygenase gene and schizophrenia in the Japanese population.

Abstract

Several lines of evidence suggest that metabolic changes in the kynurenic acid (KYNA) pathway are related to the etiology of schizophrenia. The inhibitor of kynurenine 3-monooxygenase (KMO) is known to increase KYNA levels, and the KMO gene is located in the chromosome region associated with schizophrenia, 1q42-q44. Single-marker and haplotype analyses for 6-tag single nucleotide polymorphisms (SNPs) of KMO were performed (cases = 465, controls = 440). Significant association of rs2275163 with schizophrenia was observed by single-marker comparisons (P = 0.032) and haplotype analysis including this SNP (P = 0.0049). Significant association of rs2275163 and haplotype was not replicated using a second, independent set of samples (cases = 480, controls = 448) (P = 0.706 and P = 0.689, respectively). These results suggest that the KMO is unlikely to be related to the development of schizophrenia in Japanese.

• Authors: N Aoyama, N Takahashi, S Saito, N Maeno, R Ishihara, X Ji, H Miura, M Ikeda, T Suzuki, T Kitajima, Y Yamanouchi, Y Kinoshita, K Yoshida, N Iwata, T Inada, N Ozaki
• Journal: Genes, brain, and behavior (Genes Brain Behav) Vol. 5 Issue 4 Pg. 364-8 (Jun 2006) ISSN: 1601-1848 [Print] England
• PMID: 16716206 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Kynurenine 3-Monooxygenase
• Kynurenic Acid

Topics

• Aged
• Case-Control Studies
• Chi-Square Distribution
• Chromosomes, Human, Pair 1 (genetics)
• Epigenesis, Genetic
• Female
• Gene Frequency
• Genetic Predisposition to Disease
• Humans
• Japan
• Kynurenic Acid (metabolism)
• Kynurenine 3-Monooxygenase (genetics, metabolism)
• Linkage Disequilibrium
• Male
• Middle Aged
• Polymorphism, Single Nucleotide (genetics)
• Schizophrenia (genetics)